123 related articles for article (PubMed ID: 38729348)
1. Intra-hospital variation of gut microbiota product, trimethylamine N-oxide (TMAO), predicts future major adverse cardiovascular events after myocardial infarction.
Aleksova A; Fluca AL; Stornaiuolo M; Barbati G; Pierri A; Zwas DR; Santon D; D'Errico S; Marketou M; Sinagra G; Avraham Y; Novellino E; Janjusevic M
Hellenic J Cardiol; 2024 May; ():. PubMed ID: 38729348
[TBL] [Abstract][Full Text] [Related]
2. Association between trimethylamine N-oxide and prognosis of patients with acute myocardial infarction and heart failure.
Li N; Zhou J; Wang Y; Chen R; Li J; Zhao X; Zhou P; Liu C; Song L; Liao Z; Wang X; Yan S; Zhao H; Yan H
ESC Heart Fail; 2022 Dec; 9(6):3846-3857. PubMed ID: 35686339
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
[TBL] [Abstract][Full Text] [Related]
5. Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction.
Zhou X; Jin M; Liu L; Yu Z; Lu X; Zhang H
ESC Heart Fail; 2020 Feb; 7(1):188-193. PubMed ID: 31960610
[TBL] [Abstract][Full Text] [Related]
6. Association between the Changes in Trimethylamine N-Oxide-Related Metabolites and Prognosis of Patients with Acute Myocardial Infarction: A Prospective Study.
Li N; Wang Y; Zhou J; Chen R; Li J; Zhao X; Zhou P; Liu C; Chen Y; Song L; Zhao H; Yan H; Yan S
J Cardiovasc Dev Dis; 2022 Nov; 9(11):. PubMed ID: 36354779
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
[TBL] [Abstract][Full Text] [Related]
8. Plasma trimethylamine-N-oxide, its precursors and risk of cardiovascular events in patients with acute coronary syndrome: Mediating effects of renal function.
Sanchez-Gimenez R; Peiró ÓM; Bonet G; Carrasquer A; Fragkiadakis GA; Bulló M; Papandreou C; Bardaji A
Front Cardiovasc Med; 2022; 9():1000815. PubMed ID: 36211587
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and prognosis in acute myocardial infarction.
Ng LL; Sandhu JK; Squire IB; Davies JE; Jones DJ
Int J Cardiol; 2013 Oct; 168(3):2341-6. PubMed ID: 23415169
[TBL] [Abstract][Full Text] [Related]
11. Addition of Plasma Myeloperoxidase and Trimethylamine N-Oxide to the GRACE Score Improves Prediction of Near-Term Major Adverse Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction.
Tan Y; Zhou J; Yang S; Li J; Zhao H; Song L; Yan H
Front Pharmacol; 2021; 12():632075. PubMed ID: 34650427
[No Abstract] [Full Text] [Related]
12. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
13. Trimethylamine-N-oxide has prognostic value in coronary heart disease: a meta-analysis and dose-response analysis.
Yao ME; Liao PD; Zhao XJ; Wang L
BMC Cardiovasc Disord; 2020 Jan; 20(1):7. PubMed ID: 31918665
[TBL] [Abstract][Full Text] [Related]
14. Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes.
Li XS; Obeid S; Wang Z; Hazen BJ; Li L; Wu Y; Hurd AG; Gu X; Pratt A; Levison BS; Chung YM; Nissen SE; Tang WHW; Mach F; Räber L; Nanchen D; Matter CM; Lüscher TF; Hazen SL
Eur Heart J; 2019 Aug; 40(32):2700-2709. PubMed ID: 31049589
[TBL] [Abstract][Full Text] [Related]
15. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentration of TMAO is an independent predictor of adverse outcomes in patients after acute myocardial infarction.
Gąsecka A; Fidali O; Kłębukowska A; Jasińska-Gniadzik K; Szwed P; Witkowska K; Eyileten C; Postuła M; Grabowski M; Filipiak KJ; Ufnal M
Postepy Kardiol Interwencyjnej; 2023 Mar; 19(1):31-39. PubMed ID: 37090218
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
Haghikia A; Li XS; Liman TG; Bledau N; Schmidt D; Zimmermann F; Kränkel N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Fraccarollo D; Heimesaat MM; Bauersachs J; Wang Z; Zhu W; Bavendiek U; Hazen SL; Endres M; Landmesser U
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2225-2235. PubMed ID: 29976769
[TBL] [Abstract][Full Text] [Related]
18. Trimethylamine N-Oxide Was Not Associated With 30-Day Left Ventricular Systolic Dysfunction in Patients With a First Anterior ST-Segment Elevation Myocardial Infarction After Primary Revascularization: A Sub-analysis From an Optical Coherence Tomography Registry.
Zhou J; Yu S; Tan Y; Zhou P; Liu C; Sheng Z; Li J; Chen R; Zhao S; Yan H
Front Cardiovasc Med; 2020; 7():613684. PubMed ID: 33426008
[No Abstract] [Full Text] [Related]
19. Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis.
Witkowski M; Witkowski M; Friebel J; Buffa JA; Li XS; Wang Z; Sangwan N; Li L; DiDonato JA; Tizian C; Haghikia A; Kirchhofer D; Mach F; Räber L; Matter CM; Tang WHW; Landmesser U; Lüscher TF; Rauch U; Hazen SL
Cardiovasc Res; 2022 Jul; 118(10):2367-2384. PubMed ID: 34352109
[TBL] [Abstract][Full Text] [Related]
20. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
